This example indicated that when the proportion of ER was less than 25%, 18F-FDG PET/CT might help newly diagnosed breast cancer patients find unsuspected extraaxillary lymph node metastasis and change the initial treatment plan. The gene discussed is ESR1; the disease is breast cancer.